DONATE

The “Radical Science” programme comes to an end: an alliance between science, art and humanity

On 18 June, the CCCB hosted the closing ceremony of the programme, which offered an intense schedule of debates, artistic activities and meetings open to the public over the course of five months. These events aimed to explore how science will transform the world in the coming decades.

Embryos can eliminate bacterial infections before forming their immune system, a new research shows

The work, led by a team from the CSIC and IDIBELL, with the collaboration of IBEC, manages to visualise how embryonic cells eliminate bacterial infections, before the formation of the immune system. The research describes a mechanism of phagocytosis similar to that used by white blood cells, and reveals that this mechanism is also present in human embryos.

IBEC and GIPS lead a strategic conference connecting science and clinical practice to advance translational health research

Today marked the fourth annual conference of the Interdisciplinary Group of Health Professionals (GIPS), which featured the collaboration of the Institute for Bioengineering of Catalonia (IBEC) this year. The event welcomed over 150 attendees from clinical, academic, institutional, and technological backgrounds, and aimed to strengthen interdisciplinary collaboration and promote innovation in health.

Una sola dosis de nanorrobots aniquila un 90% del tumor en cáncer de vejiga

Un ejército de nanorrobots circula utilizando como combustible urea. Su misión: transportar radiación para atacar las células malignas de la vejiga. No es ciencia ficción, sino el avance que han logrado Meritxell Serra-Casablancas y Samuel Sánchez en el Institut de Bioenginyeria de Catalunya (IBEC), y que han publicado en Nature Nanotechnology. Su estudio ha demostrado que estos nanorrobots tienen una alta eficacia para reducir el volumen de los tumores en ratones.

Ibec Seminar. Dr. Maribel Vazquez

Microfluidic Modeling of Aging Retina Dr. Maribel Vazquez,, Professor of Biomedical Engineering Rutgers, The State University of New Jersey. https://vazlab.org The dramatic rise of chronic and age-related eye diseases is … Read more

Scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies

This is an analysis on an unprecedented scale. They studied over 140,000 versions of the Aβ42 peptide, which forms harmful plaques in the brain. It is the first map to reveal how mutations affect a protein in its transition state — a fleeting phase that is difficult to study. This finding opens up new avenues for preventing Alzheimer’s disease and suggests a method that can be applied to studying other proteins involved in different pathologies. The study, published in Science Advances, is a collaboration between the Wellcome Sanger Institute in the United Kingdom, the Institute for Bioengineering of Catalonia, and the Centre for Genomic Regulation in Barcelona.